NOREPINEPHRINE BITARTRATE
| Brand name | NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE |
|---|---|
| Active ingredient | NOREPINEPHRINE BITARTRATE |
| Strength | EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | January 2021 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 12097170 | March 2041 | product |
| 12290494 | March 2041 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.